Coya Therapeutics, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | -40.8% | +123.6% | |
| – | – | +27,250.8% | +24.7% | +115.7% | -99.8% | |
| – | – | – | – | -1,760.1% | – | |
| – | +580.7% | +94.2% | +22.4% | +96.7% | +40.7% | |
| – | +245.8% | +109.6% | +61.6% | +13.4% | +28.9% | |
| – | +367.3% | +10.9% | +55.6% | +6.4% | +215.3% | |
| – | – | – | – | – | – | |
| – | -44.9% | +11,225.8% | – | – | – | |
| – | – | – | – | – | – | |
| – | – | – | -70.2% | -199.5% | – | |
| – | – | – | – | – | – | |
| – | -46,824.1% | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.